Search Items: MULTIPLE SCLEROSIS, . hits: 480
Abdelhak, A; Bachhuber, F; Ning, K; Benkert, P; John, Boscardin, W; Maleska, Maceski, A; Schaedelin, S; Achtnichts, L; Finkener, S; Lalive, PH; Uginet, M; Pot, C; Du, Pasquier, R; Hoepner, R; Chan, A; Gobbi, C; Zecca, C; Müller, S; Roth, P; Granziera, C; Chitnis, T; Madill, E; Weiner, HL; Green, AJ; Hauser, SL; Cree, BA; Kümpfel, T; Havla, J; Skripuletz, T; Gingele, S; Senel, M; Vardakas, I; Taranu, D; Ziemann, U; Kowarik, MC; Kleiter, I; Hoshi, MM; Zettl, UK; Haarmann, A; Thebault, S; Freedman, MS; Bergman, HP; Iacobaeus, E; Khademi, M; Ferraro, D; Cardi, M; Mariotto, S; Comabella, M; Montalban, X; Vilaseca-Jolonch, A; Strijbis, EM; Wessels, MH; Killestein, J; Hemmer, B; Held, F; Sellebjerg, F; Højsgaard, Chow, H; Alvarez-Lafuente, R; Domínguez-Mozo, MI; Hegen, H; Berek, K; Deisenhammer, F; Thouvenot, E; Agherbi, H; Rejdak, K; Gąsior, M; Tzanetakos, D; Tzartos, JS; Sormani, MP; Dujmovic, Basuroski, I; Arrambide, G; Khalil, M; Piehl, F; Teunissen, CE; Kuhle, J; Tumani, H
Blood biomarkers for predicting disability worsening in progressive multiple sclerosis: a multinational, individual participant-level analysis.
J Neurol Neurosurg Psychiatry. 2025;
Doi: 10.1136/jnnp-2025-335831
Web of Science
PubMed
FullText
FullText_MUG
Androdias, G; Lünemann, JD; Maillart, E; Amato, MP; Audoin, B; Bruijstens, AL; Bsteh, G; Butzkueven, H; Ciccarelli, O; Cobo-Calvo, A; Derfuss, T; Di, Pauli, F; Edan, G; Enzinger, C; Geraldes, R; Granziera, C; Hacohen, Y; Hartung, HP; Hynes, S; Inglese, M; Kappos, L; Kuusisto, H; Langer-Gould, A; Magyari, M; Marignier, R; Montalban, X; Mycko, MP; Nourbakhsh, B; Oh, J; Oreja-Guevara, C; Piehl, F; Prosperini, L; Sastre-Garriga, J; Sellebjerg, F; Selmaj, K; Siva, A; Tallantyre, E; van, Pesch, V; Vukusic, S; Weinstock-Guttman, B; Zipp, F; Tintoré, M; Iacobaeus, E; Stankoff, B
De-escalating and discontinuing disease-modifying therapies in multiple sclerosis.
Brain. 2024;
Doi: 10.1093/brain/awae409
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Benkert, P; Maleska, Maceski, A; Schaedelin, S; Oechtering, J; Zadic, A; Vilchez, Gomez, JF; Melie-Garcia, L; Cagol, A; Galbusera, R; Subramaniam, S; Lorscheider, J; Galli, E; Mueller, J; Fischer-Barnicol, B; Achtnichts, L; Findling, O; Lalive, PH; Bridel, C; Uginet, M; Müller, S; Pot, C; Mathias, A; Du, Pasquier, R; Salmen, A; Hoepner, R; Chan, A; Disanto, G; Zecca, C; D'Souza, M; Hemkens, LG; Yaldizli, Ö; Derfuss, T; Roth, P; Gobbi, C; Brassat, D; Tackenberg, B; Pedotti, R; Raposo, C; Oksenberg, J; Wiendl, H; Berger, K; Hermesdorf, M; Piehl, F; Conen, D; Buser, A; Kappos, L; Khalil, M; Granziera, C; Abdelhak, A; Leppert, D; Willemse, EAJ; Kuhle, J, , Swiss, MS, Cohort, study, (SMSC)
Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B-Cell Depleting Treatment in Multiple Sclerosis.
Ann Neurol. 2024;
Doi: 10.1002/ana.27096
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Bsteh, G; Hoepner, R; Gernert, JA; Berek, K; Gradl, C; Kliushnikova, D; Damulina, A; Traxler, G; Föttinger, F; Habernig, S; Krajnc, N; Betancourt, AXL; Ponleitner, M; Zrzavy, T; Deisenhammer, F; Di Pauli, F; Havla, J; Khalil, M; Kümpfel, T; Wipfler, P; Chan, A; Berger, T; Hammer, H; Hegen, H
Switching from natalizumab to antiCD20 monoclonal antibodies: Short transition interval is associated with improved outcome
EUR J NEUROL. 2025; 32(1): e16587
Doi: 10.1111/ene.16587
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Fissolo, N; Schaedelin, S; Villar, LM; Lünemann, JD; Correale, J; Rejdak, K; Schwab, N; Vilaseca, A; Held, F; García-Merino, A; Bittner, S; Trojano, M; Furlan, R; Tumani, H; Pérez-Miralles, F; Rosenstein, I; Galimberti, D; Álvarez-Bravo, G; Thouvenot, E; Llufriu, S; Khoury, SJ; Hoepner, R; Martínez-Yélamos, S; Hegen, H; Drulovic, J; Téllez-Lara, N; Khalil, M; Oechtering, J; Pérez-Sempere, Á; Rodríguez-Antigüedad, A; Enrique-Martínez, J; Strijbis, E; Killestein, J; Eichau, S; Colombo, E; Schaller-Nagengast, J; Midaglia, L; Sánchez-López, AJ; Monreal, E; Chan, A; Paul, F; Rovira, À; Tintoré, M; Lycke, J; Zipp, F; Hemmer, B; Kuhle, J; Montalban, X; Comabella, M; Zettl, UK; Falk, S; Gutiérrez, L; Gasior, M; Veiga, González, JL; Ferrer, R; Quiroga-Varela, A; Bachhuber, F; Costa-Frossard, L, , RIS, Study, Group
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome.
JAMA Neurol. 2025;
Doi: 10.1001/jamaneurol.2025.1481
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Helmlinger, B; Seebacher, B; Ropele, S; Hechenberger, S; Heschl, B; Reishofer, G; Jordan, S; Tinauer, C; Wurth, S; Valsasina, P; Rocca, MA; Filippi, M; Ehling, R; Reindl, M; Khalil, M; Deisenhammer, F; Brenneis, C; Enzinger, C; Pinter, D
Effects of rhythmic-cued gait training on gait-like task related brain activation in people with multiple sclerosis.
J Neurol Sci. 2025; 471: 123426
Doi: 10.1016/j.jns.2025.123426
Web of Science
PubMed
FullText
FullText_MUG
Hochmeister, S; Rakusa, M; Moro, E; Bereczki, D; Cavallieri, F; Fanciulli, A; Filipović, SR; Guekht, A; Helbok, R; Boneschi, FM; Özturk, S; Priori, A; Willekens, B; Ramankulov, D; Sellner, J
Is there still hesitancy towards SARS-CoV-2 vaccination among people with neurological disease- a survey of the NeuroCOVID-19 task force of the European Academy of Neurology.
Neurol Sci. 2025;
Doi: 10.1007/s10072-025-08017-w
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Konen, FF; Wurster, U; Schwenkenbecher, P; Gerritzen, A; Groß, CC; Eichhorn, P; Harrer, A; Isenmann, S; Lewczuk, P; Lewerenz, J; Leypoldt, F; Otto, M; Regeniter, A; Roskos, M; Ruprecht, K; Spreer, A; Strik, H; Uhr, M; Wick, M; Wildemann, B; Wiltfang, J; Zimmermann, T; Hannich, M; Khalil, M; Tumani, H; Süße, M; Skripuletz, T, , German, Society, for, Cerebrospinal, Fluid, Diagnostics, and, Clinical, Neurochemistry, (DGLN, e.V.)
Oligoclonal bands and kappa free light chains: Competing parameters or complementary biomarkers?
Autoimmun Rev. 2025; 103765
Doi: 10.1016/j.autrev.2025.103765
Web of Science
PubMed
FullText
FullText_MUG
Pontillo, G; Prados, F; Wink, AM; Kanber, B; Bisecco, A; Broeders, TAA; Brunetti, A; Cagol, A; Calabrese, M; Castellaro, M; Cocozza, S; Colato, E; Collorone, S; Cortese, R; De, Stefano, N; Douw, L; Enzinger, C; Filippi, M; Foster, MA; Gallo, A; Gonzalez-Escamilla, G; Granziera, C; Groppa, S; Harbo, HF; Høgestøl, EA; Llufriu, S; Lorenzini, L; Martinez-Heras, E; Messina, S; Moccia, M; Nygaard, GO; Palace, J; Petracca, M; Pinter, D; Rocca, MA; Strijbis, E; Toosy, A; Valsasina, P; Vrenken, H; Ciccarelli, O; Cole, JH; Schoonheim, MM; Barkhof, F, , MAGNIMS, study, group
More Than the Sum of Its Parts: Disrupted Core Periphery of Multiplex Brain Networks in Multiple Sclerosis.
Hum Brain Mapp. 2025; 46(1): e70107
Doi: 10.1002/hbm.70107
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
van Nederpelt, DR; Mendelsohn, ZC; Bos, L; Mattiesing, RM; Ciccarelli, O; Sastre-Garriga, J; Carrasco, FP; Kuijer, JPA; Vrenken, H; Killestein, J; Schoonheim, MM; Moraal, B; Yousry, T; Pontillo, G; Rovira, A; Strijbis, EMM; Jasperse, B; Barkhof, F; Toosy, AT; Filippi , M; Enzinger, C; Gasperini, C; Cristina; De Stefano; De Luca; Rocca, MA; Sastre-Garriga, J
User requirements for quantitative radiological reports in multiple sclerosis
EUR RADIOL. 2025;
Doi: 10.1007/s00330-025-11544-x
Web of Science
PubMed
FullText
FullText_MUG
Walter, E; Traunfellner, M; Meyer, F; Enzinger, C; Guger, M; Bsteh, C; Altmann, P; Hegen, H; Goger, C; Mikl, V
Cost-effectiveness of the Floodlight® MS app in Austria. Unlocking the mystery of costs and outcomes of a digital health application for patients with multiple sclerosis.
Digit Health. 2025; 11:20552076251314550
Doi: 10.1177/20552076251314550
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Woh, PY; Chen, Y; Kumpitsch, C; Mohammadzadeh, R; Schmidt, L; Moissl-Eichinger, C
Reevaluation of the gastrointestinal methanogenic archaeome in multiple sclerosis and its association with treatment.
Microbiol Spectr. 2025; e0218324
Doi: 10.1128/spectrum.02183-24
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Yaldizli, Ö; Benkert, P; Achtnichts, L; Bar-Or, A; Bohner-Lang, V; Bridel, C; Comabella, M; Findling, O; Disanto, G; Finkener, S; Gobbi, C; Granziera, C; Herwerth, M; Hoepner, R; Horakova, D; Kamber, N; Khalil, M; Kunz, P; Lalive, P; Linker, R; Lorscheider, J; Müller, S; Oechtering, J; Pettypool, V; Piehl, F; Pot, C; Roth, P; Théaudin, M; Tintore, M; Tur, C; Uffer, D; Uginet, M; Vehoff, J; Wiendl, H; Ziemssen, T; Zecca, C; Salmen, A; Leppert, D; Derfuss, T; Kappos, L; Hemkens, LG; Janiaud, P; Kuhle, J
Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study.
Mult Scler. 2025; 13524585251335466
Doi: 10.1177/13524585251335466
Web of Science
PubMed
FullText
FullText_MUG
Angiari, S; Carlucci, T; Budui, SL; Bach, SD; Dusi, S; Walter, J; Ellmeier, E; Schnabl, A; Stracke, A; Bordag, N; Tafrali, C; Demjaha, R; Khalil, M; Angelini, G; Terrabuio, E; Pietronigro, EC; Zenaro, E; Laudanna, C; Rossi, B; Constantin, G
Coenzyme A fueling with pantethine limits autoreactive T cell pathogenicity in experimental neuroinflammation.
J Neuroinflammation. 2024; 21(1): 287
Doi: 10.1186/s12974-024-03270-w
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Cagol, A; Cortese, R; Barakovic, M; Schaedelin, S; Ruberte, E; Absinta, M; Barkhof, F; Calabrese, M; Castellaro, M; Ciccarelli, O; Cocozza, S; De, Stefano, N; Enzinger, C; Filippi, M; Jurynczyk, M; Maggi, P; Mahmoudi, N; Messina, S; Montalban, X; Palace, J; Pontillo, G; Pröbstel, AK; Rocca, MA; Ropele, S; Rovira, À; Schoonheim, MM; Sowa, P; Strijbis, E; Wattjes, MP; Sormani, MP; Kappos, L; Granziera, C, , MAGNIMS, Study, Group
Diagnostic Performance of Cortical Lesions and the Central Vein Sign in Multiple Sclerosis.
JAMA Neurol. 2024; 81(2):143-153
Doi: 10.1001/jamaneurol.2023.4737
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Filipović, SR; Özturk, S; Bereczki, D; Bodini, B; Cavallieri, F; Fanciulli, A; Guekht, A; Helbok, R; Hochmeister, S; Martinelli, Boneschi, F; Priori, A; Rakusa, M; Romoli, M; Willekens, B; Zedde, M; Sellner, J; Moro, E, , Neuro, COVID‐19, Task, Force, of, the, European, Academy, of, Neurology
Management of patients with neurological diseases considering post-pandemic coronavirus disease 2019 (COVID-19) related risks and dangers - An updated European Academy of Neurology consensus statement.
Eur J Neurol. 2024; 31(10):e16408
Doi: 10.1111/ene.16408
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Filippi, M; Preziosa, P; Barkhof, F; Ciccarelli, O; Cossarizza, A; De, Stefano, N; Gasperini, C; Geraldes, R; Granziera, C; Haider, L; Lassmann, H; Margoni, M; Pontillo, G; Ropele, S; Rovira, À; Sastre-Garriga, J; Yousry, TA; Rocca, MA
The ageing central nervous system in multiple sclerosis: the imaging perspective.
Brain. 2024; 147(11):3665-3680
Doi: 10.1093/brain/awae251
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Fissolo, N; Benkert, P; Sastre-Garriga, J; Mongay-Ochoa, N; Vilaseca-Jolonch, A; Llufriu, S; Blanco, Y; Hegen, H; Berek, K; Perez-Miralles, F; Rejdak, K; Villar, LM; Monreal, E; Alvarez-Lafuente, R; Soylu, OK; Abdelhak, A; Bachhuber, F; Tumani, H; Martínez-Yélamos, S; Sánchez-López, AJ; García-Merino, A; Gutiérrez, L; Castillo-Trivino, T; Lycke, J; Rosenstein, I; Furlan, R; Filippi, M; Téllez, N; Ramió-Torrentà, L; Lünemann, JD; Wiendl, H; Eichau, S; Khalil, M; Kuhle, J; Montalban, X; Comabella, M
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis.
J Neurol Neurosurg Psychiatry. 2024; 95(5):410-418
Doi: 10.1136/jnnp-2023-332251
Web of Science
PubMed
FullText
FullText_MUG
Freedman, MS; Gnanapavan, S; Booth, RA; Calabresi, PA; Khalil, M; Kuhle, J; Lycke, J; Olsson, T, , Consortium, of, Multiple, Sclerosis, Centers
Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management.
EBioMedicine. 2024; 101: 104970
Doi: 10.1016/j.ebiom.2024.104970
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Geraldes, R; Arrambide, G; Banwell, B; Rovira, À; Cortese, R; Lassmann, H; Messina, S; Rocca, MA; Waters, P; Chard, D; Gasperini, C; Hacohen, Y; Mariano, R; Paul, F; DeLuca, GC; Enzinger, C; Kappos, L; Leite, MI; Sastre-Garriga, J; Yousry, T; Ciccarelli, O; Filippi, M; Barkhof, F; Palace, J, , MAGNIMS, Study, Group
The influence of MOGAD on diagnosis of multiple sclerosis using MRI.
Nat Rev Neurol. 2024;
Doi: 10.1038/s41582-024-01005-2
Web of Science
PubMed
FullText
FullText_MUG
Guger, M; Enzinger, C; Leutmezer, F; Di, Pauli, F; Kraus, J; Kalcher, S; Kvas, E; Berger, T, , Austrian, MS, Treatment, Registry, (AMSTR)
Early intensive versus escalation treatment in patients with relapsing-remitting multiple sclerosis in Austria.
J Neurol. 2024;
Doi: 10.1007/s00415-024-12256-w
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Haindl, MT; Üçal, M; Tafrali, C; Wonisch, W; Erdogan, C; Nowakowska, M; Adzemovic, MZ; Enzinger, C; Khalil, M; Hochmeister, S
Sex Differences under Vitamin D Supplementation in an Animal Model of Progressive Multiple Sclerosis.
Nutrients. 2024; 16(4):
Doi: 10.3390/nu16040554
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hechenberger, S; Helmlinger, B; Tinauer, C; Jauk, E; Ropele, S; Heschl, B; Wurth, S; Damulina, A; Eppinger, S; Demjaha, R; Khalil, M; Enzinger, C; Pinter, D
Evaluation of a self-administered iPad®-based processing speed assessment for people with multiple sclerosis in a clinical routine setting.
J Neurol. 2024; 271(6):3268-3278
Doi: 10.1007/s00415-024-12274-8
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hegen, H; Berek, K; Deisenhammer, F; Berger, T; Enzinger, C; Guger, M; Kraus, J; Walde, J; Di, Pauli, F
Sex impacts treatment decisions in multiple sclerosis.
J Neurol. 2024;
Doi: 10.1007/s00415-024-12270-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Helmlinger, B; Pinter, D; Hechenberger, S; Bachmaier, G; Khalil, M; Heschl, B; Damulina, A; Pichler, A; Enzinger, C
Evaluation of the T25FW in minimally disabled people with multiple sclerosis.
J Neurol Sci. 2024; 462: 123073
Doi: 10.1016/j.jns.2024.123073
Web of Science
PubMed
FullText
FullText_MUG
Kaddoura, R; Faraji, H; Othman, M; Abu, Hijleh, A; Loney, T; Goswami, N; Benamer, HTS
Exploring Factors Associated with Falls in Multiple Sclerosis: Insights from a Scoping Review.
Clin Interv Aging. 2024; 19: 923-938.
Doi: 10.2147/CIA.S460475
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Khalil, M; Teunissen, CE; Lehmann, S; Otto, M; Piehl, F; Ziemssen, T; Bittner, S; Sormani, MP; Gattringer, T; Abu-Rumeileh, S; Thebault, S; Abdelhak, A; Green, A; Benkert, P; Kappos, L; Comabella, M; Tumani, H; Freedman, MS; Petzold, A; Blennow, K; Zetterberg, H; Leppert, D; Kuhle, J
Neurofilaments as biomarkers in neurological disorders - towards clinical application.
Nat Rev Neurol. 2024; 20(5): 269-287.
Doi: 10.1038/s41582-024-00955-x
Web of Science
PubMed
FullText
FullText_MUG
Kiss, C; Wurth, S; Heschl, B; Khalil, M; Gattringer, T; Enzinger, C; Ropele, S
Low-frequency MR elastography reveals altered deep gray matter viscoelasticity in multiple sclerosis.
Neuroimage Clin. 2024; 42: 103606
Doi: 10.1016/j.nicl.2024.103606
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Lazzarotto, A; Hamzaoui, M; Tonietto, M; Dubessy, AL; Khalil, M; Pirpamer, L; Ropele, S; Enzinger, C; Battaglini, M; Stromillo, ML; De, Stefano, N; Filippi, M; Rocca, MA; Gallo, P; Gasperini, C; Stankoff, B; Bodini, B, , MAGNIMS, Study, Group
Time is myelin: early cortical myelin repair prevents atrophy and clinical progression in multiple sclerosis.
Brain. 2024; 147(4):1331-1343
Doi: 10.1093/brain/awae024
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Niehaus, P; Gonzalez, de, Vega, R; Haindl, MT; Birkl, C; Leoni, M; Birkl-Toeglhofer, AM; Haybaeck, J; Ropele, S; Seeba, M; Goessler, W; Karst, U; Langkammer, C; Clases, D
Multimodal analytical tools for the molecular and elemental characterisation of lesions in brain tissue of multiple sclerosis patients.
Talanta. 2024; 270:125518
Doi: 10.1016/j.talanta.2023.125518
Web of Science
PubMed
FullText
FullText_MUG
Peternell, A; Lechner, C; Breu, M; Preisel, M; Schimmel, M; Eisenkölbl, A; Zobel, J; Wendel, EM; Reindl, M; Rostásy, K; Baumann, M
Blood parameters in pediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.
Eur J Paediatr Neurol. 2024; 50:86-95
Doi: 10.1016/j.ejpn.2024.04.011
Web of Science
PubMed
FullText
FullText_MUG
Pontillo, G; Prados, F; Colman, J; Kanber, B; Abdel-Mannan, O; Al-Araji, S; Bellenberg, B; Bianchi, A; Bisecco, A; Brownlee, WJ; Brunetti, A; Cagol, A; Calabrese, M; Castellaro, M; Christensen, R; Cocozza, S; Colato, E; Collorone, S; Cortese, R; De, Stefano, N; Enzinger, C; Filippi, M; Foster, MA; Gallo, A; Gasperini, C; Gonzalez-Escamilla, G; Granziera, C; Groppa, S; Hacohen, Y; Harbo, HFF; He, A; Hogestol, EA; Kuhle, J; Llufriu, S; Lukas, C; Martinez-Heras, E; Messina, S; Moccia, M; Mohamud, S; Nistri, R; Nygaard, GO; Palace, J; Petracca, M; Pinter, D; Rocca, MA; Rovira, A; Ruggieri, S; Sastre-Garriga, J; Strijbis, EM; Toosy, AT; Uher, T; Valsasina, P; Vaneckova, M; Vrenken, H; Wingrove, J; Yam, C; Schoonheim, MM; Ciccarelli, O; Cole, JH; Barkhof, F
Disentangling Neurodegeneration From Aging in Multiple Sclerosis Using Deep Learning: The Brain-Predicted Disease Duration Gap.
Neurology. 2024; 103(10):e209976
Doi: 10.1212/WNL.0000000000209976
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Queissner, R; Fellendorf, FT; Dalkner, N; Bengesser, SA; Maget, A; Birner, A; Platzer, M; Reininghaus, B; Häussl, A; Schönthaler, E; Tmava-Berisha, A; Lenger, M; Reininghaus, EZ
The influence of chronic inflammation on the illnesscourse of bipolar disorder: A longitudinal study.
J Psychiatr Res. 2024; 174: 258-262.
Doi: 10.1016/j.jpsychires.2024.04.024
Web of Science
PubMed
FullText
FullText_MUG
Rocca, MA; Preziosa, P; Barkhof, F; Brownlee, W; Calabrese, M; De Stefano, N; Granziera, C; Ropele, S; Toosy, AT; Vidal-Jordana, A; Di Filippo, M; Filippi, M
Current and future role of MRI in the diagnosis and prognosis of multiple sclerosis
LANCET REG HEALTH-EU. 2024; 44: 100978
Doi: 10.1016/j.lanepe.2024.100978
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Sastre-Garriga, J; Vidal-Jordana, A; Toosy, AT; Enzinger, C; Granziera, C; Frederiksen, J; Ciccarelli, O; Filippi, M; Montalban, X; Tintore, M; Pareto, D; Rovira, À, , MAGNIMS, Study, Group
Value of Optic Nerve MRI in Multiple Sclerosis Clinical Management: A MAGNIMS Position Paper and Future Perspectives.
Neurology. 2024; 103(3):e209677
Doi: 10.1212/WNL.0000000000209677
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Seebacher, B; Helmlinger, B; Hotz, I; Pinter, D; Ehling, R; Enzinger, C; Deisenhammer, F; Brenneis, C
Actual and imagined music-cued gait training for people with multiple sclerosis: a multicentre qualitative study.
BMJ Open. 2024; 14(7): e086555
Doi: 10.1136/bmjopen-2024-086555
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Seebacher, B; Helmlinger, B; Pinter, D; Heschl, B; Ehling, R; Hechenberger, S; Reindl, M; Khalil, M; Enzinger, C; Deisenhammer, F; Brenneis, Md, C
Actual and Imagined Music-Cued Gait Training in People with Multiple Sclerosis: A Double-Blind Randomized Parallel Multicenter Trial.
Neurorehabil Neural Repair. 2024; 15459683241260724
Doi: 10.1177/15459683241260724
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Serranová, T; Di, Vico, I; Tinazzi, M; Aybek, S; Bilic, E; Binzer, S; Bøen, E; Bruggeman, A; Bratanov, C; Cabreira, VRA; Golder, D; Dunalska, A; Falup-Pecurariu, C; Garcin, B; Gelauff, J; Laffan, A; Podnar, S; Pareés, I; Plender, T; Popkirov, S; Romanenko, V; Schwingenschuh, P; Seliverstov, Y; Sjöström, C; Škorvánek, M; Stamelou, M; Zailskas, D; Edwards, MJ; Stone, J
Functional neurological disorder in Europe: regional differences in education and health policy.
Eur J Neurol. 2024; 31(10):e16350
Doi: 10.1111/ene.16350
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Sommer, M; Singer, C; Werkl, P; Seidel, G
Intermediate uveitis
SPEKTRUM AUGENHEILKD. 2024;
Doi: 10.1007/s00717-023-00565-w
Web of Science
FullText
FullText_MUG
Tourell, M; Jin, J; Bachrata, B; Stewart, A; Ropele, S; Enzinger, C; Bollmann, S; Bollmann, S; Robinson, SD; O'Brien, K; Barth, M
Three-dimensional EPI with shot-selective CAIPIRIHANA for rapid high-resolution quantitative susceptibility mapping at 3 T.
Magn Reson Med. 2024; 92(3):997-1010
Doi: 10.1002/mrm.30101
Web of Science
PubMed
FullText
FullText_MUG
Wilson, D; Chan, D; Chang, L; Mathis, R; Verberk, I; Montalban, X; Comabella, M; Fissolo, N; Bielekova, B; Masvekar, R; Chitnis, T; Ziemssen, T; Akgün, K; Blennow, K; Zetterberg, H; Brück, W; Giovannoni, G; Gnanapavan, S; Bittner, S; Zipp, F; Comi, G; Furlan, R; Lehmann, S; Thebault, S; Freedman, M; Bar-Or, A; Kramer, M; Otto, M; Halbgebauer, S; Hrusovsky, K; Plavina, T; Khalil, M; Piehl, F; Wiendl, H; Kappos, L; Maceski, A; Willemse, E; Leppert, D; Teunissen, C; Kuhle, J
Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injury.
Clin Chem Lab Med. 2024; 62(2):322-331
Doi: 10.1515/cclm-2023-0518
Web of Science
PubMed
FullText
FullText_MUG
Bachrata, B; Bollmann, S; Jin, J; Tourell, M; Dal-Bianco, A; Trattnig, S; Barth, M; Ropele, S; Enzinger, C; Robinson, SD
Super-resolution QSM in little or no additional time for imaging (NATIve) using 2D EPI imaging in 3 orthogonal planes.
Neuroimage. 2023; 283:120419
Doi: 10.1016/j.neuroimage.2023.120419
Web of Science
PubMed
FullText
FullText_MUG
Balazs, I; Horvath, A; Heschl, B; Khalil, M; Enzinger, C; Stadlbauer, V; Seifert-Held, T
Anti-CD20 treatment and neutrophil function in central nervous system demyelinating diseases.
J Neuroimmunol. 2023; 381:578136
Doi: 10.1016/j.jneuroim.2023.578136
Web of Science
PubMed
FullText
FullText_MUG
Berek, K; Bauer, A; Rudzki, D; Auer, M; Barket, R; Zinganell, A; Lerch, M; Hofer, L; Grams, A; Poskaite, P; Wurth, S; Berger, T; Di Pauli, F; Deisenhammer, F; Hegen, H; Reindl, M
Immune profiling in multiple sclerosis: a single-center study of 65 cytokines, chemokines, and related molecules in cerebrospinal fluid and serum
FRONT IMMUNOL. 2023; 14: 1200146
Doi: 10.3389/fimmu.2023.1200146
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Buchmann, A; Pirpamer, L; Pinter, D; Voortman, M; Helmlinger, B; Pichler, A; Maceski, AM; Benkert, P; Bachmaier, G; Ropele, S; Reindl, M; Leppert, D; Kuhle, J; Enzinger, C; Khalil, M
High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis.
Eur J Neurol. 2023; 30(5):1389-1399
Doi: 10.1111/ene.15742
Web of Science
PubMed
FullText
FullText_MUG
Callegari, I; Oechtering, J; Schneider, M; Perriot, S; Mathias, A; Voortman, MM; Cagol, A; Lanner, U; Diebold, M; Holdermann, S; Kreiner, V; Becher, B; Granziera, C; Junker, A; Du, Pasquier, R; Khalil, M; Kuhle, J; Kappos, L; Sanderson, NSR; Derfuss, T
Cell-binding IgM in CSF is distinctive of multiple sclerosis and targets the iron transporter SCARA5.
Brain. 2023;
Doi: 10.1093/brain/awad424
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Callegari, I; Schneider, M; Aebischer, V; Voortman, MM; Proschmann, U; Ziemssen, T; Lindberg, R; Fischer-Barnicol, B; Khalil, M; Kappos, L; Kuhle, J; Sanderson, NSR; Derfuss, T
Natalizumab in cerebrospinal fluid and breastmilk of patients with multiple sclerosis.
Ther Adv Neurol Disord. 2023; 16: 17562864221150040
Doi: 10.1177/17562864221150040
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Dalla, Costa, G; Nos, C; Zabalza, A; Buron, M; Magyari, M; Sellebjerg, F; Guerrero, AI; Roselli, L; La, Porta, ML; Martinis, M; Bailon, R; Kontaxis, S; Laporta, E; Garcia, E; Pokorny, FB; Schuller, BW; Folarin, A; Stewart, C; Leocani, L; Vairavan, S; Cummins, N; Dobson, R; Hotopf, M; Narayan, V; Montalban, X; Sorensen, PS; Comi, G
A wearable device perspective on the standard definitions of disability progression in multiple sclerosis.
Mult Scler. 2023; 13524585231214362
Doi: 10.1177/13524585231214362
Web of Science
PubMed
FullText
FullText_MUG
Gast, LV; Platt, T; Nagel, AM; Gerhalter, T
Recent technical developments and clinical research applications of sodium (23Na) MRI.
Prog Nucl Magn Reson Spectrosc. 2023; 138-139: 1-51.
Doi: 10.1016/j.pnmrs.2023.04.002
Web of Science
PubMed
FullText
FullText_MUG
Guger, M; Enzinger, C; Leutmezer, F; Di, Pauli, F; Kraus, J; Kalcher, S; Kvas, E; Berger, T, , Austrian, MS, Treatment, Registry, (AMSTR)
Effects of horizontal versus vertical switching of disease-modifying treatment after platform drugs on disease activity in patients with relapsing-remitting multiple sclerosis in Austria.
J Neurol. 2023; 270(6):3103-3111
Doi: 10.1007/s00415-023-11644-y
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Show the next 50 results of search